FDA mulls compounding for peptides previously flagged over safety risks BioSpace In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA takes first step in possible reversal of ban on some peptides The Washington Post Compounded "semaglutide" is not FDA approved semaglutide.com